Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis

Joseph R. Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B. Cook and Steven Larson
Journal of Nuclear Medicine April 2010, 51 (4) 543-550; DOI: https://doi.org/10.2967/jnumed.108.060459
Joseph R. Osborne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Port
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mithat Gonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Doane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Yeung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Gerald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josh B. Cook
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Larson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    (A) 18F-FDG accumulation correlates weakly with tumor size. (B–D) Neither HER2 status (B), node status (C), nor PR status (D) correlates with maximum SUV. (E) Accumulation does correlate with ER status. Open circles denote tumor samples subjected to microarray analysis. Closed circles do not have gene profiles.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Twenty tumors clustered into 2 groups of 10 each on basis of genomewide expression profile. (A) Complete gene list. (B) ER and ER-related genes were main grouping discriminators.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Overlap between validated ER status gene list (generated from tumor bank of 99 women) and the 500 genes whose expression most correlated with SUV from our sample of 20 tumors (P < 0.001).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    A Select Subset of Genes That Most Correlated with Increased Tumor 18F-FDG Uptake

    RankSUV correlationDescription
    40.817High-affinity aspartate glutamate transporter member 6 (SLAC1A6) mRNA
    50.815Thymosin β identified in neuroblastoma cells (TMSNB) mRNA
    80.793Human galactosyltransferase–associated protein kinase (p58GTA) mRNA
    9−0.788Subunit B (B56)
    230.751Orosomucoid 1 (ORM1) mRNA
    250.749Transmembrane phosphatase with tensin homology (TPTE) mRNA
    260.746Orosomucoid 2 (ORM2) mRNA
    280.739TTK protein kinase mRNA
    330.732Mitotic spindle-coiled coil-related protein (DEEPEST) mRNA
    350.729Ubiquitin-conjugating enzyme E2A (RAD6 homolog) (UBE2A) mRNA
    430.717Malic enzyme 1, NADP(+)-dependent cytosolic (ME1) mRNA
    500.711Cellular retinoic acid–binding protein 1 (CRABP1) mRNA
    590.707Regulator of G protein signaling-Z (RGSZ1) mRNA
    780.692Hexokinase 3 (white cell) (HK3) mRNA
    880.685Ubiquitin-conjugating enzyme E2D
    970.679L-type amino acid transporter 1
    345−0.597Facilitated glucose transporter member 8 (SLC2A8) mRNA
    1,5820.515Human CDC6-related protein (HsCDC6) mRNA
    6,1370.334Homo sapiens centromere protein F (CENPF) mRNA
    • mRNA = messenger RNA.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Data Supplement 1
    • Data Supplement 2
    • Data Supplement 3
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (4)
Journal of Nuclear Medicine
Vol. 51, Issue 4
April 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis
Joseph R. Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B. Cook, Steven Larson
Journal of Nuclear Medicine Apr 2010, 51 (4) 543-550; DOI: 10.2967/jnumed.108.060459

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis
Joseph R. Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B. Cook, Steven Larson
Journal of Nuclear Medicine Apr 2010, 51 (4) 543-550; DOI: 10.2967/jnumed.108.060459
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men
  • Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer
  • Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
  • Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer
  • Imaging Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysis
  • Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
  • Oestrogen-related tumour phenotype: positron emission tomography characterisation with 18F-FDG and 18F-FES
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire